Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 121

1.

Effect of vessel preservation on splenic volume and function in patients with spleen preserving distal pancreatectomies.

Yohanathan L, Loveday BPT, Brar N, Greig PD, McGilvray ID, Moulton CA, Gallinger S, Wei AC, Cleary SP.

HPB (Oxford). 2020 Feb 17. pii: S1365-182X(20)30031-9. doi: 10.1016/j.hpb.2020.01.012. [Epub ahead of print]

PMID:
32081539
2.

The Ubiquitin-Specific Protease 18 Promotes Hepatitis C Virus Production by Increasing Viral Infectivity.

Li Y, Ma MX, Qin B, Lin LT, Richardson CD, Feld J, McGilvray ID, Chen L.

Mediators Inflamm. 2019 Nov 18;2019:3124745. doi: 10.1155/2019/3124745. eCollection 2019.

3.

Donor outcomes in anonymous live liver donation.

Goldaracena N, Jung J, Aravinthan AD, Abbey SE, Krause S, Pritlove C, Lynch J, Wright L, Selzner N, Stunguris J, Greig P, Ghanekar A, McGilvray I, Sapisochin G, Ng VL, Levy G, Cattral M, Grant D.

J Hepatol. 2019 Nov;71(5):951-959. doi: 10.1016/j.jhep.2019.06.027. Epub 2019 Jul 4.

PMID:
31279899
4.

The basis of liver regeneration: A systems biology approach.

Bhat M, Pasini E, Baciu C, Angeli M, Humar A, Macparland S, Feld J, McGilvray I.

Ann Hepatol. 2019 May - Jun;18(3):422-428. doi: 10.1016/j.aohep.2018.07.003. Epub 2019 Apr 25.

5.

Metastatic low-grade endometrial stromal sarcoma of uterus presenting as a primary pancreatic tumor: case presentation and literature review.

McCarthy AJ, Clarke BA, McGilvray I, Dickson BC, Khalili K, Chetty R.

Diagn Pathol. 2019 Apr 22;14(1):30. doi: 10.1186/s13000-019-0807-3. Review.

6.

The Impact of Preexisting and Post-transplant Diabetes Mellitus on Outcomes Following Liver Transplantation.

Aravinthan AD, Fateen W, Doyle AC, Venkatachalapathy SV, Issachar A, Galvin Z, Sapisochin G, Cattral MS, Ghanekar A, McGilvray ID, Selzner M, Grant DR, Selzner N, Lilly LB, Renner EL, Bhat M.

Transplantation. 2019 Dec;103(12):2523-2530. doi: 10.1097/TP.0000000000002757.

PMID:
30985734
7.

Cancer-related gene expression is associated with disease severity and modifiable lifestyle factors in non-alcoholic fatty liver disease.

Arendt BM, Teterina A, Pettinelli P, Comelli EM, Ma DWL, Fung SK, McGilvray ID, Fischer SE, Allard JP.

Nutrition. 2019 Jun;62:100-107. doi: 10.1016/j.nut.2018.12.001. Epub 2018 Dec 13.

PMID:
30870804
8.

Management and surveillance of non-functional pancreatic neuroendocrine tumours: Retrospective review.

Yohanathan L, Dossa F, St Germain AT, Golbafian F, Moulton CA, McGilvray ID, Greig PD, Serra S, Wei AC, Jhaveri KS, Gallinger S, Cleary SP.

Pancreatology. 2019 Mar;19(2):360-366. doi: 10.1016/j.pan.2019.02.008. Epub 2019 Feb 18.

PMID:
30803874
9.

Effect of portal vein embolization on treatment plan prior to major hepatectomy for hepatocellular carcinoma.

Loveday BPT, Jaberi A, Moulton CA, Wei AC, Gallinger S, Beecroft R, Fischer S, Ghanekar A, McGilvray I, Sapisochin G, Greig PD, Tan K, Cleary SP.

HPB (Oxford). 2019 Aug;21(8):1072-1078. doi: 10.1016/j.hpb.2018.12.009. Epub 2019 Feb 20.

PMID:
30797726
10.

Live donor liver transplantation for patients with hepatocellular carcinoma offers increased survival vs. deceased donation.

Goldaracena N, Gorgen A, Doyle A, Hansen BE, Tomiyama K, Zhang W, Ghanekar A, Lilly L, Cattral M, Galvin Z, Selzner M, Bhat M, Selzner N, McGilvray I, Greig PD, Grant DR, Sapisochin G.

J Hepatol. 2019 Apr;70(4):666-673. doi: 10.1016/j.jhep.2018.12.029. Epub 2019 Jan 8.

PMID:
30630009
11.

Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3 cm in potentially transplantable patients.

Doyle A, Gorgen A, Muaddi H, Aravinthan AD, Issachar A, Mironov O, Zhang W, Kachura J, Beecroft R, Cleary SP, Ghanekar A, Greig PD, McGilvray ID, Selzner M, Cattral MS, Grant DR, Lilly LB, Selzner N, Renner EL, Sherman M, Sapisochin G.

J Hepatol. 2019 May;70(5):866-873. doi: 10.1016/j.jhep.2018.12.027. Epub 2019 Jan 5.

PMID:
30615906
12.

Predictors of De Novo Nonalcoholic Fatty Liver Disease After Liver Transplantation and Associated Fibrosis.

Galvin Z, Rajakumar R, Chen E, Adeyi O, Selzner M, Grant D, Sapisochin G, Greig P, Cattral M, McGilvray I, Ghanekar A, Selzner N, Lilly L, Patel K, Bhat M.

Liver Transpl. 2019 Jan;25(1):56-67. doi: 10.1002/lt.25338.

13.

Neoadjuvant therapy and major arterial resection for potentially reconstructable arterial involvement by stage 3 adenocarcinoma of the pancreas.

Loveday BPT, Zilbert N, Serrano PE, Tomiyama K, Tremblay A, Fox AM, Segedi M, O'Malley M, Borgida A, Bianco T, Creighton S, Dodd A, Fraser A, Moore M, Kim J, Cleary S, Moulton CA, Greig P, Wei AC, Gallinger S, Dhani N, McGilvray ID.

HPB (Oxford). 2019 Jun;21(6):643-652. doi: 10.1016/j.hpb.2018.10.004. Epub 2018 Nov 22.

PMID:
30471960
14.

Patient blood management for liver resection: consensus statements using Delphi methodology.

Hallet J, Jayaraman S, Martel G, Ouellet JB, Lin Y, McCluskey S, Beyfuss KA, Karanicolas PJ; Canadian Hepato-Pancreatico-Biliary Association group.

HPB (Oxford). 2019 Apr;21(4):393-404. doi: 10.1016/j.hpb.2018.09.022. Epub 2018 Nov 13.

PMID:
30446290
15.

Altered hepatic genes related to retinol metabolism and plasma retinol in patients with non-alcoholic fatty liver disease.

Pettinelli P, Arendt BM, Teterina A, McGilvray I, Comelli EM, Fung SK, Fischer SE, Allard JP.

PLoS One. 2018 Oct 31;13(10):e0205747. doi: 10.1371/journal.pone.0205747. eCollection 2018.

16.

Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations.

MacParland SA, Liu JC, Ma XZ, Innes BT, Bartczak AM, Gage BK, Manuel J, Khuu N, Echeverri J, Linares I, Gupta R, Cheng ML, Liu LY, Camat D, Chung SW, Seliga RK, Shao Z, Lee E, Ogawa S, Ogawa M, Wilson MD, Fish JE, Selzner M, Ghanekar A, Grant D, Greig P, Sapisochin G, Selzner N, Winegarden N, Adeyi O, Keller G, Bader GD, McGilvray ID.

Nat Commun. 2018 Oct 22;9(1):4383. doi: 10.1038/s41467-018-06318-7.

17.

Renal outcomes following left renal vein harvest for venous reconstruction during pancreas and liver surgery.

Loveday BPT, Dib MJ, Sequeira S, Alotaiby N, Visser R, Barbas AS, Wei AC, Cleary SP, Moulton CA, Gallinger S, Greig PD, McGilvray ID.

HPB (Oxford). 2019 Jan;21(1):114-120. doi: 10.1016/j.hpb.2018.07.015. Epub 2018 Oct 13.

PMID:
30322713
18.

Living Donor Liver Transplantation Using Selected Grafts With 2 Bile Ducts Compared With 1 Bile Duct Does Not Impact Patient Outcome.

Kollmann D, Goldaracena N, Sapisochin G, Linares I, Selzner N, Hansen BE, Bhat M, Cattral MS, Greig PD, Lilly L, McGilvray ID, Ghanekar A, Grant DR, Selzner M.

Liver Transpl. 2018 Nov;24(11):1512-1522. doi: 10.1002/lt.25197.

19.

Splenectomy as Flow Modulation Strategy and Risk Factors of De Novo Portal Vein Thrombosis in Adult-to-Adult Living Donor Liver Transplantation.

Linares I, Goldaracena N, Rosales R, Maza L, Kaths M, Kollmann D, Echeverri J, Selzner N, McCluskey SA, Sapisochin G, Lilly LB, Greig P, Bhat M, Ghanekar A, Cattral M, McGilvray I, Grant D, Selzner M.

Liver Transpl. 2018 Sep;24(9):1209-1220. doi: 10.1002/lt.25212.

20.

Live donor liver transplantation with older donors: Increased long-term graft loss due to HCV recurrence.

Goldaracena N, Barbas AS, Galante A, Sapisochin G, Al-Adra D, Selzner N, Galvin Z, Cattral MS, Greig PD, Lilly L, Bhat M, McGilvray ID, Ghanekar A, Levy G, Grant DR, Selzner M.

Clin Transplant. 2018 Aug;32(8):e13304. doi: 10.1111/ctr.13304. Epub 2018 Jul 16.

PMID:
29947154

Supplemental Content

Loading ...
Support Center